Mediwound to participate in upcoming investor conferences in january

Yavne, israel, jan. 05, 2021 (globe newswire) -- mediwound ltd. (nasdaq: mdwd), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that it will participate in the forthcoming lifesci partners 10th annual corporate access event and the h.c. wainwright bioconnect 2021 conference. both conferences will take place virtually.
MDWD Ratings Summary
MDWD Quant Ranking